XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 06, 2023 7:00pm EST
New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy Jan 04, 2023 7:30am EST
XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon Nov 22, 2022 7:01am EST
XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events Nov 03, 2022 7:30am EDT
XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events Aug 04, 2022 7:30am EDT
